PTC596-LMS (Leiomyosarcoma) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out if a study drug called unesbulin is a safe and effective option that can help people with a type of soft tissue sarcoma called leiomyosarcoma.
Who Can Participate in the Study?
Adults ages 18+ who are diagnosed with locally advanced leiomyosarcoma.
For more information on who can participate in this study please contact the study team at email@example.com.
What is Involved?
If you choose to join this study, you will get a random assignment to 1 of 2 groups:
- One group will the study drug in combination with a standard drug called dacarbazine
- The other group will get a placebo (inactive substance that has no drug in it) in combination with dacarbazine
No matter to which group you are assigned, during the study you will:
- Have physical exams, electrocardiograms (ECG), and blood draws
- Have CT or MRI scans
You will visit our clinic for follow-up visits after you stop taking the study drugs, and we will keep in touch with you to see how you are feeling.